F2G
Oral antifungal therapy developer to treat life-threatening rare fungal infections
5
Funding Rounds
$302.6m
Money raised
Overview
Oral antifungal therapy developer to treat life-threatening rare fungal infections
- Website:
- Business model: B2B
- Headquarters: Manchester
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company F2G has raised a total of $302.55m in funding over 5 rounds.
Key Insights:
- F2G Series D Round, September 2024: $100m
- F2G August 2022 Funding Round: $70m
- F2G , August 2020: $60.8m
- F2G , June 2016: $60m
- F2G funding round, August 2008: $11.75m
F2G Series D Round, September 2024
$100m
F2G August 2022 Funding Round
$70m
F2G , August 2020
$60.8m
F2G , June 2016
$60m
F2G funding round, August 2008
$11.75m
Industries
F2G is active in the following industries: